Literature DB >> 6154788

Homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular CSF of comatose patients with obstructive hydrocephalus.

T Inagawa, S Ishikawa, T Uozumi.   

Abstract

Ventricular cerebrospinal fluid (CSF) levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) were determined every 2 to 4 hours over a period of 1 to 4 days in 12 patients, consisting of seven cases of brain tumor, two cases of cerebrovascular disease, and three cases of head injury. The concentrations of HVA and 5-HIAA varied with time in all cases, and significant correlations were found between the two values in eight cases. However, the relationship between variations of HVA and 5-HIAA levels and rhythms of sleep and waking could not be clarified. Both HVA and 5-HIAA concentrations varied at high levels in two patients whose CSF flow was completely blocked by tumor at the site of the fourth ventricle and aqueduct, respectively. On the contrary, in a case with craniopharyngioma in the third ventricle which blocked the bilateral foramina of Monro, although the HVA values were high, the 5-HIAA values varied at low levels. Of five comatose patients, two had cerebrovascular lesions and three had sustained head injury, and, in four of the five, the values of either one or both of HVA and 5-HIAA were low, but in the fifth case the 5-HIAA value was high. Estimation of HVA and 5-HIAA concentrations in ventricular CSF may be a valuable tool in the investigation of brain monoamine metabolism. However, many factors must be considered in the interpretation of results of clinical studies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154788     DOI: 10.3171/jns.1980.52.5.0635

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

Review 1.  Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury.

Authors:  Pramod K Dash; Jing Zhao; Georgene Hergenroeder; Anthony N Moore
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

2.  Catecholamine alterations in experimental hydrocephalus.

Authors:  H Miyake; P O Eghwrudjakpor; T Sakamoto; K Mori
Journal:  Childs Nerv Syst       Date:  1992-08       Impact factor: 1.475

3.  CSF neurotransmitter metabolites in comatose head injury patients during changes in their clinical state.

Authors:  M Markianos; A Seretis; A Kotsou; M Christopoulos
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

4.  Monoamine neurotransmitters and their metabolites in the mature rabbit brain following induction of hydrocephalus.

Authors:  M R Del Bigio; J E Bruni; J P Vriend
Journal:  Neurochem Res       Date:  1998-11       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.